Drug-induced neuropsychiatric adverse events using post-marketing surveillance.

CONCLUSION: Our results should raise physicians' awareness of drugs associated with abnormal behavior, but further investigation of these medications is warranted.
PMID: 33588740 [PubMed - as supplied by publisher]

Source: Current Clinical Pharmacology - February 14, 2021 Category: Drugs & Pharmacology Authors: Wakabayashi T, Nakatsuji T, Kambara H, Niinomi I, Oyama S, Inada A, Ueno S, Uchida M, Iwanaga K, Iida T, Hosohata K Tags: Curr Clin Pharmacol Source Type: research